Latest Breaking News On - Magendie neurocenter - Page 1 : comparemela.com

Results of Aelis Farma Combined General Meeting of May 24, 2023

Regulatory News: Aelis Farma (ISIN: FR0014007ZB4 Ticker: AELIS), a clinical-stage biopharmaceutical company specialized in the development of treatments for brain diseases, announces that all the

Aelis Farma: Combined General Meeting of May 24, 2023: Availability of Preparatory Documents and Participation and Voting Procedures

Aelis Farma (ISIN: FR0014007ZB4 Ticker: AELIS, PEA-PME eligible) (Paris: AELIS), a clinical-stage biopharmaceutical company specialized in the development of treatments for brain diseases, informs

Aelis Farma: Publication of the 2022 Universal Registration Document

Regulatory News: Aelis Farma (ISIN: FR0014007ZB4 Ticker: AELIS) (Paris: AELIS), a clinical-stage biopharmaceutical company specialized in the development of treatments for brain diseases, announces

Aelis Farma: Publication of the 2022 Universal Registration Document

Degroof Petercam Initiates the Coverage of Aelis Farma With a "Buy" Recommendation